APA

Brunen D., García-Barchino M. J., Malani D., Jagalur Basheer N., Lieftink C., Beijersbergen R. L., Murumägi A., Porkka K., Wolf M., Zwaan C. M., Fornerod M., Kallioniemi O., Martínez-Climent J. Á. & Bernards R. (20180202). Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling. : Oncotarget.

Chicago

Brunen Diede, García-Barchino María José, Malani Disha, Jagalur Basheer Noorjahan, Lieftink Cor, Beijersbergen Roderick L, Murumägi Astrid, Porkka Kimmo, Wolf Maija, Zwaan C Michel, Fornerod Maarten, Kallioniemi Olli, Martínez-Climent José Ángel and Bernards René. 20180202. Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling. : Oncotarget.

Harvard

Brunen D., García-Barchino M. J., Malani D., Jagalur Basheer N., Lieftink C., Beijersbergen R. L., Murumägi A., Porkka K., Wolf M., Zwaan C. M., Fornerod M., Kallioniemi O., Martínez-Climent J. Á. and Bernards R. (20180202). Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling. : Oncotarget.

MLA

Brunen Diede, García-Barchino María José, Malani Disha, Jagalur Basheer Noorjahan, Lieftink Cor, Beijersbergen Roderick L, Murumägi Astrid, Porkka Kimmo, Wolf Maija, Zwaan C Michel, Fornerod Maarten, Kallioniemi Olli, Martínez-Climent José Ángel and Bernards René. Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling. : Oncotarget. 20180202.